Aliya Omer

Aliya Z. Omer is an accomplished professional with a diverse educational background and extensive experience in the pharmaceutical and biotechnology industry. She holds a BS in Materials Science Engineering and Biomedical Engineering from Carnegie Mellon University and an MBA in Business from INSEAD.

Aliya currently serves as the Vice President and Head of Global Portfolio and Program Strategy at Kite Pharma. Prior to this role, she held various leadership positions at both Kite Pharma and Novartis, including Vice President, Corporate Development Global Program Lead; Vice President, Solid Tumors Franchise Sales; and General Manager. Her tenure at Novartis also includes roles such as Executive Business Director, Oncology Franchise; Product Director for Zykadia; Director for BCR ABL Diagnostics; Associate Director for the Tasigna Brand Team; and Oncology Sales Specialist.

Before her time at Novartis, Aliya Z. Omer worked as a Senior Product Manager for Global New Products and Portfolio Strategy at Novartis and as a Staff Scientist at Johnson & Johnson.